Sun Pharma, Intrexon Form JV To Develop Anti-Blindness Treatments
This article was originally published in PharmAsia News
Executive Summary
Sun Pharmaceutical Industries has formed a joint venture with Intrexon to develop gene-based treatments for ocular diseases such as macular degeneration, glaucoma and retinitis.